ASNS Archives - Page 2 of 2 - Blue Horseshoe Stocks

A Winning Wednesday:

We were exceedingly pleased with the performance from our daily options trading ideas yesterday. Our premarket report for Wednesday was loaded with good ideas, with all of our targets posting significant intraday upswings. It continued a perfect streak that we’ve got going so far this week, and hope to maintain through today and tomorrow’s reports.

Yesterday’s potential plays were the AMD Weekly $149-148 Puts, the AMZN Weekly $177.50-180 Calls, the CVS Weekly $61-59 Puts, and the SBUX Weekly $78-77 Puts. These were the biggest continuous runs they established on the day:

AMD Weekly $149-148 Puts
$149: 1.88-7.33 (+290%)
$148: 1.51-6.50 (+330%)
_____

AMZN Weekly $177.50-180 Calls
$177.50: 2.24-8.00 (+257%)
$180: 1.32-5.85 (+343%)
_____

CVS Weekly $61-59 Puts
$61 3.90-6.95 (+78%)
$60: 3.67-5.55 (+51%)
$59: 2.63-4.45 (+69%)
_____

SBUX Weekly $78-77 Puts
$78: 2.00-5.29 (+163%)
$77: 1.18-4.35 (+269%)

Fresh Options Ideas:
SPY 05/02 $502-504 Calls*
QCOM Weekly $172.50-175 Calls
DASH Weekly $120-118 Puts

*Trading options contracts on their day of expiration should only be attempted by experienced traders

Extended Watchlist:
ALLR, CNTX, EBS, ASNS, RDGL, ALYI,

Hemp, Inc. HEMP

Because of the absolute bloodbath having been experienced by the market of late, it is easy to forget the huge development for those with vested interests in hemp, the male form of the cannabis plant. Of course, one of its biggest proponents for quite some time has been the aptly named, Hemp, Inc.

The recent passing of the farm bill that effectively green-lighted the hemp industry nationwide is a game changer, and it certainly showed up on the chart, which experienced a heck of a spike. Following our alert on HEMP from just a few weeks ago, the stock ran from .0292 up as high as .054, a move of 85%

There has been some pullback since then, but in general HEMP is a stock that we’re going to be very interested in tracking into the New Year. There is a golden cross setup in the works for the chart, so we could be looking at the next leg-up sooner rather than later.

The company has talked a big talk when it comes to federal legalization, and now that it has become a reality, we expect to see solid efforts from HEMP in 2019, starting with the cleaning up of its reporting status on OTC Markets.

Extended Watchlist:
ASNS, IMMU, MB,

Tag: ASNS

Weekly Win Streak Upheld, 3 New Ideas

Blue Horseshoe Stocks: HEMP Update